Listas | Seção | Observação |
---|---|---|
WHO Model List of Essential Medicines (2021) | 12.1. Antianginal medicines |
Outras observações: Includes metoprolol and carvedilol as alternatives. |
WHO Model List of Essential Medicines (2021) | 12.2. Antiarrhythmic medicines |
Outras observações: Includes metoprolol and carvedilol as alternatives. |
WHO Model List of Essential Medicines (2021) | 12.3. Antihypertensive medicines |
Outras observações: Therapeutic alternatives: atenolol, carvedilol, metoprolol. Atenolol should not be used as a first-line agent in uncomplicated hypertension in patients > 60 years. |
WHO Model List of Essential Medicines (2021) | 12.4. Medicines used in heart failure |
Outras observações: Includes metoprolol and carvedilol as alternatives. |
PAHO Strategic Fund Medicine List | 6.1. Antihypertensive medicines |
Outras observações: Metoprolol and carvedilol as alternatives. |
Listas | Seção | Observação |
---|---|---|
WHO Model List of Essential Medicines (2021) | 12.1. Antianginal medicines |
Outras observações: Includes metoprolol and carvedilol as alternatives. |
WHO Model List of Essential Medicines (2021) | 12.2. Antiarrhythmic medicines |
Outras observações: Includes metoprolol and carvedilol as alternatives. |
WHO Model List of Essential Medicines (2021) | 12.3. Antihypertensive medicines |
Outras observações: Therapeutic alternatives: atenolol, carvedilol, metoprolol. Atenolol should not be used as a first-line agent in uncomplicated hypertension in patients > 60 years. |
WHO Model List of Essential Medicines (2021) | 12.4. Medicines used in heart failure |
Outras observações: Includes metoprolol and carvedilol as alternatives. |
PAHO Strategic Fund Medicine List | 6.1. Antihypertensive medicines |
Outras observações: Metoprolol and carvedilol as alternatives. |
Listas | Seção | Observação |
---|---|---|
Peru | 12.4 Medications Used in Cardiac Insufficiency | Sem observações |